Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

GenSight enrols first patient for GS030 trial

Back of the eye of a person with mid-stage retinitis pigmentosa. Credit: Hamel; licensee BioMed Central Ltd.



  • Retinitis pigmentosa

Go Top